Related Experiment Video
Updated: Jun 19, 2026
Optimization of Antigen Preparation for Hemagglutination Inhibition Assay of Newcastle Disease Virus Serology
Published on: January 24, 2025
AN EXPERIMENTAL TEST OF NUZUM'S ANTIPOLIOMYELITIC SERUM
Abstract:
The antistreptococcic serum of Nuzum and Willy has failed to show in the monkey neutralizing or therapeutic power when applied by their methods against small doses of the virus of poliomyelitis. Under the same conditions the serum of monkeys recovered from experimental poliomyelitis proved neutralizing and protective. The experimental and other evidence adduced by those who regard the streptococcus as playing an essential part in the pathology of epidemic poliomyelitis and the antistreptococcic sera as exhibiting therapeutic properties for man and monkeys is regarded as imperfect and inconclusive.
Insights
Nuzum and Willy
Area of Science:
- Virology
- Immunology
- Microbiology
Background:
- The role of streptococcus in poliomyelitis pathogenesis remains debated.
- Antistreptococcic sera have been proposed as a potential treatment for poliomyelitis.
- Previous research suggested therapeutic properties of antistreptococcic sera in poliomyelitis.
Purpose of the Study:
- To evaluate the efficacy of antistreptococcic serum against poliomyelitis virus.
- To assess the neutralizing and therapeutic potential of antistreptococcic serum in primate models.
- To investigate the role of streptococcus in poliomyelitis.
Main Methods:
- Monkeys were inoculated with small doses of poliomyelitis virus.
- Antistreptococcic serum from Nuzum and Willy was administered.
- Serum from recovered poliomyelitis monkeys was used as a control.
Main Results:
- Antistreptococcic serum showed no neutralizing or therapeutic effect in monkeys.
- Serum from recovered monkeys demonstrated neutralizing and protective properties.
- Evidence supporting streptococcus's role in poliomyelitis and serum efficacy was deemed inconclusive.
Conclusions:
- Antistreptococcic serum is ineffective against poliomyelitis virus in primate models.
- Poliomyelitis recovery serum offers protection, suggesting endogenous immune responses are key.
- The hypothesis of streptococcus involvement in poliomyelitis requires further rigorous investigation.
